Mar 2, 2026

Featuring perspectives from Dr Hope S Rugo and Dr Sara M Tolaney, including the following topics:

• Introduction: Long-Term Outcomes with Antibody-Drug Conjugates (0:00)
• HER2-Positive Breast Cancer (8:02)
• HER2-Negative Breast Cancer (32:41)

CME information and select...

Mar 1, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Antibody-Drug Conjugates for Breast Cancer | Faculty Presentation 2: Current and Emerging Role of TROP2-Directed ADCs — Sara M Tolaney, MD, MPH

CME information and select...

Feb 28, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Antibody-Drug Conjugates for Breast Cancer | Faculty Presentation 1: Current and Emerging Role of HER2-Directed Antibody-Drug Conjugates (ADCs) — Hope S Rugo, MD

CME information and select...

Jan 27, 2026

Featuring perspectives from Dr Angela DeMichele, Dr Komal Jhaveri, Dr Erica Mayer, Dr Hope S Rugo and Dr Seth Wander, including the following topics: 

• Introduction (0:00)
• 1985 NCI Consensus Conference on Early Breast Cancer: Sir Richard Peto, FRS (2:01)
• Current Role of Genomic Assays in Treatment Decision-Making...

Jan 14, 2026

Featuring perspectives from Prof Giuseppe Curigliano, Prof Nadia Harbeck, Dr Ian E Krop, Dr Nancy U Lin and Dr Joyce O’Shaughnessy, including the following topics: 

• Introduction (0:00)
• Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Prof Harbeck (1:39)
• Case: A woman in her mid...